# American Red Cross Blood Services – FDA Inspection, May 7, 2026

Source: https://www.keypedia.com/records/fda_inspections/american-red-cross-blood-services/61c90725-3965-4388-bcc2-1f600c5b6223
Source feed: FDA_Inspections

> FDA inspection 1316906 of American Red Cross Blood Services, May 07, 2026. Classification: No Action Indicated (NAI). 7 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1316906
- Company Name: American Red Cross Blood Services
- Inspection Date: 2026-05-07
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1180256 - 2022-09-07
- FDA Inspection 1056215 - 2018-05-15
- FDA Inspection 965411 - 2016-04-07
- FDA Inspection 863671 - 2014-01-28
- FDA Inspection 772139 - 2012-03-19

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/la-tasha-m-gunter/db9cd9cf-db0a-4c31-9f7c-24760750f34d)

Company: https://www.keypedia.com/companies/american-red-cross-blood-services/34067cb4-83a6-44a0-9cfc-2e0637b3f7d7

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d